Annual CFI
$144.64 M
+$311.49 M+186.69%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual cash flow from investing activities is $144.64 million, with the most recent change of +$311.49 million (+186.69%) on December 31, 2023.
- During the last 3 years, CHRS annual CFI has risen by +$159.04 million (+1104.37%).
- CHRS annual CFI is now at all-time high.
Performance
CHRS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$444.00 K
-$27.21 M-98.39%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly cash flow from investing activities is $444.00 thousand, with the most recent change of -$27.21 million (-98.39%) on September 30, 2024.
- Over the past year, CHRS quarterly CFI has dropped by -$50.10 million (-99.12%).
- CHRS quarterly CFI is now -99.79% below its all-time high of $210.06 million, reached on December 31, 2020.
Performance
CHRS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$266.07 M
-$50.10 M-15.85%
September 30, 2024
Summary
- As of February 7, 2025, CHRS TTM cash flow from investing activities is $266.07 million, with the most recent change of -$50.10 million (-15.85%) on September 30, 2024.
- Over the past year, CHRS TTM CFI has increased by +$286.53 million (+1400.36%).
- CHRS TTM CFI is now -19.34% below its all-time high of $329.88 million, reached on March 31, 2024.
Performance
CHRS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CHRS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +186.7% | -99.1% | +1400.4% |
| 3 y3 years | +1104.4% | -98.9% | +472.3% |
| 5 y5 years | +10000.0% | -98.9% | +472.3% |
CHRS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +186.7% | -99.8% | +100.3% | -19.3% | +259.5% |
| 5 y | 5-year | at high | +186.7% | -99.8% | +100.2% | -19.3% | +189.2% |
| alltime | all time | at high | +186.7% | -99.8% | +100.2% | -19.3% | +189.2% |
Coherus BioSciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $444.00 K(-98.4%) | $266.07 M(-15.8%) |
| Jun 2024 | - | $27.66 M(-86.4%) | $316.17 M(-4.2%) |
| Mar 2024 | - | $202.76 M(+476.0%) | $329.88 M(+128.1%) |
| Dec 2023 | $144.64 M(-186.7%) | $35.20 M(-30.4%) | $144.64 M(-806.9%) |
| Sep 2023 | - | $50.55 M(+22.2%) | -$20.46 M(-71.4%) |
| Jun 2023 | - | $41.37 M(+136.0%) | -$71.46 M(-37.2%) |
| Mar 2023 | - | $17.53 M(-113.5%) | -$113.71 M(-31.8%) |
| Dec 2022 | -$166.85 M(+20.5%) | -$129.90 M(>+9900.0%) | -$166.85 M(-336.5%) |
| Sep 2022 | - | -$457.00 K(-48.1%) | $70.54 M(-18.9%) |
| Jun 2022 | - | -$880.00 K(-97.5%) | $86.98 M(-22.0%) |
| Mar 2022 | - | -$35.62 M(-133.1%) | $111.45 M(-180.5%) |
| Dec 2021 | -$138.41 M(+861.1%) | $107.49 M(+572.2%) | -$138.41 M(+286.1%) |
| Sep 2021 | - | $15.99 M(-32.2%) | -$35.84 M(+1.2%) |
| Jun 2021 | - | $23.59 M(-108.3%) | -$35.43 M(-88.1%) |
| Mar 2021 | - | -$285.48 M(-235.9%) | -$298.26 M(+1971.1%) |
| Dec 2020 | -$14.40 M(+13.1%) | $210.06 M(+1180.3%) | -$14.40 M(-93.8%) |
| Sep 2020 | - | $16.41 M(-106.9%) | -$230.52 M(-6.8%) |
| Jun 2020 | - | -$239.25 M(>+9900.0%) | -$247.22 M(<-9900.0%) |
| Mar 2020 | - | -$1.62 M(-73.3%) | $851.00 K(-106.7%) |
| Dec 2019 | -$12.73 M | -$6.06 M(+1997.6%) | -$12.73 M(-239.7%) |
| Sep 2019 | - | -$289.00 K(-103.3%) | $9.12 M(-59.0%) |
| Jun 2019 | - | $8.82 M(-158.0%) | $22.22 M(-793.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$15.20 M(-196.3%) | -$3.21 M(+169.9%) |
| Dec 2018 | -$1.19 M(-73.1%) | $15.79 M(+23.2%) | -$1.19 M(-54.0%) |
| Sep 2018 | - | $12.81 M(-177.2%) | -$2.58 M(-119.4%) |
| Jun 2018 | - | -$16.60 M(+26.0%) | $13.31 M(-60.8%) |
| Mar 2018 | - | -$13.18 M(-191.6%) | $33.98 M(-869.3%) |
| Dec 2017 | -$4.42 M(-32.2%) | $14.39 M(-49.9%) | -$4.42 M(-80.3%) |
| Sep 2017 | - | $28.71 M(+606.3%) | -$22.37 M(-56.6%) |
| Jun 2017 | - | $4.06 M(-107.9%) | -$51.58 M(-7.8%) |
| Mar 2017 | - | -$51.58 M(+1346.4%) | -$55.95 M(+758.7%) |
| Dec 2016 | -$6.51 M(-6.2%) | -$3.57 M(+613.2%) | -$6.51 M(+48.3%) |
| Sep 2016 | - | -$500.00 K(+66.1%) | -$4.39 M(-37.9%) |
| Jun 2016 | - | -$301.00 K(-86.0%) | -$7.08 M(-9.1%) |
| Mar 2016 | - | -$2.15 M(+48.8%) | -$7.78 M(+12.0%) |
| Dec 2015 | -$6.95 M(+1223.6%) | -$1.44 M(-54.6%) | -$6.95 M(+15.7%) |
| Sep 2015 | - | -$3.18 M(+215.9%) | -$6.00 M(+65.5%) |
| Jun 2015 | - | -$1.01 M(-23.2%) | -$3.63 M(-7.3%) |
| Mar 2015 | - | -$1.31 M(+163.1%) | -$3.91 M(+645.1%) |
| Dec 2014 | -$525.00 K(+40.8%) | -$499.00 K(-38.2%) | -$525.00 K(+1919.2%) |
| Sep 2014 | - | -$807.00 K(-37.6%) | -$26.00 K(-103.3%) |
| Jun 2014 | - | -$1.29 M(-162.3%) | $781.00 K(-62.3%) |
| Mar 2014 | - | $2.07 M | $2.07 M |
| Dec 2013 | -$373.00 K(-79.5%) | - | - |
| Dec 2012 | -$1.82 M | - | - |
FAQ
- What is Coherus BioSciences annual cash flow from investing activities?
- What is the all time high annual CFI for Coherus BioSciences?
- What is Coherus BioSciences annual CFI year-on-year change?
- What is Coherus BioSciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Coherus BioSciences?
- What is Coherus BioSciences quarterly CFI year-on-year change?
- What is Coherus BioSciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Coherus BioSciences?
- What is Coherus BioSciences TTM CFI year-on-year change?
What is Coherus BioSciences annual cash flow from investing activities?
The current annual CFI of CHRS is $144.64 M
What is the all time high annual CFI for Coherus BioSciences?
Coherus BioSciences all-time high annual cash flow from investing activities is $144.64 M
What is Coherus BioSciences annual CFI year-on-year change?
Over the past year, CHRS annual cash flow from investing activities has changed by +$311.49 M (+186.69%)
What is Coherus BioSciences quarterly cash flow from investing activities?
The current quarterly CFI of CHRS is $444.00 K
What is the all time high quarterly CFI for Coherus BioSciences?
Coherus BioSciences all-time high quarterly cash flow from investing activities is $210.06 M
What is Coherus BioSciences quarterly CFI year-on-year change?
Over the past year, CHRS quarterly cash flow from investing activities has changed by -$50.10 M (-99.12%)
What is Coherus BioSciences TTM cash flow from investing activities?
The current TTM CFI of CHRS is $266.07 M
What is the all time high TTM CFI for Coherus BioSciences?
Coherus BioSciences all-time high TTM cash flow from investing activities is $329.88 M
What is Coherus BioSciences TTM CFI year-on-year change?
Over the past year, CHRS TTM cash flow from investing activities has changed by +$286.53 M (+1400.36%)